Further characterization of the metabolic properties of triglyceride-rich lipoproteins from human and mouse apoC-III transgenic mice
about
Apolipoprotein C3 SstI polymorphism and triglyceride levels in Asian IndiansEffects of apoA-V on HDL and VLDL metabolism in APOC3 transgenic miceApolipoprotein A-V gene therapy for disease prevention / treatment:a critical analysisExpression of apolipoprotein C-III in McA-RH7777 cells enhances VLDL assembly and secretion under lipid-rich conditionsFunctional analysis of the missense APOC3 mutation Ala23Thr associated with human hypotriglyceridemiaAdiponectin resistance and vascular dysfunction in the hyperlipidemic stateDietary interventions that lower lipoproteins containing apolipoprotein C-III are more effective in whites than in blacks: results of the OmniHeart trial.A rare variant in APOC3 is associated with plasma triglyceride and VLDL levels in Europeans.Plasma apolipoprotein C-III levels, triglycerides, and coronary artery calcification in type 2 diabetics.LDL Receptor-Related Protein-1 (LRP1) Regulates Cholesterol Accumulation in Macrophages.Associations of the APOC3 rs5128 polymorphism with plasma APOC3 and lipid levels: a meta-analysisEffect of apolipoprotein C3 genetic polymorphisms on serum lipid levels and the risk of intracerebral hemorrhage.Intermittent hypoxia inhibits clearance of triglyceride-rich lipoproteins and inactivates adipose lipoprotein lipase in a mouse model of sleep apnoea.Antisense inhibition of apoB synthesis with mipomersen reduces plasma apoC-III and apoC-III-containing lipoproteinsApolipoprotein CIII overexpression exacerbates diet-induced obesity due to adipose tissue higher exogenous lipid uptake and retention and lower lipolysis rates.Catalytically inactive lipoprotein lipase expression in muscle of transgenic mice increases very low density lipoprotein uptake: direct evidence that lipoprotein lipase bridging occurs in vivo.Retinoids increase human apo C-III expression at the transcriptional level via the retinoid X receptor. Contribution to the hypertriglyceridemic action of retinoids.Overexpression of apolipoprotein C-III decreases secretion of dietary triglyceride into lymphA human APOC3 missense variant and monoclonal antibody accelerate apoC-III clearance and lower triglyceride-rich lipoprotein levels.Key differences between apoC-III regulation and expression in intestine and liver.Pleiotropic effects of apolipoprotein C3 on HDL functionality and adipose tissue metabolic activity.Association of serum lipids and coronary artery disease with polymorphisms in the apolipoprotein AI-CIII-AIV gene cluster.Apolipoproteins E and CIII interact to regulate HDL metabolism and coronary heart disease risk.Gemcabene downregulates inflammatory, lipid-altering and cell-signaling genes in the STAM™ model of NASH.
P2860
Q21283798-388F0433-4CFA-48D8-806D-7B577950EA19Q24302828-D2E02136-9D8D-4E98-A67C-87526D9748C2Q26775009-EF343B9E-F6E2-4F42-91D8-2F5CD343EA8AQ28252652-5D6A784E-5D4E-43F6-A1AB-F5600AFBE942Q28271254-0AE59756-AE6D-4801-81E2-1E368BBD4B66Q33577630-D59827C3-DE93-4D9E-B0E0-1CF408EEA45BQ34119914-F00FB655-3518-4AD0-B0D6-708A08BB97BCQ34205523-8D74B2B6-0FD7-45C0-8459-47895C969DEEQ34480492-1BC016A2-3020-4961-A222-7E0CAC1968BAQ35659751-6C0770A7-108D-43CE-8902-06BCA6725910Q35687045-8C9BB33A-3B71-470F-BE5F-4AC79D33A908Q35814923-2AA7C9CE-F65D-4C30-8C25-4F055C0C8F24Q35830163-D38A0539-12C0-4E8B-8BE5-758032468C09Q35839701-CB6090FD-A7EE-4185-A2F5-7E33730C6CA2Q36401998-FEB716CE-122B-4281-8BC4-36C498E825D6Q36801691-3FF96525-8CDB-4CD2-8DD9-BD74BC3F52D0Q37384407-19107895-191D-427A-8D61-E19BA48E2703Q37727877-52F2A3E1-0C5A-4BF3-8A79-99427E95CD73Q38616263-0C6810E2-8E47-450E-9B25-8113EEB93E78Q38664013-168A3D14-703D-44C6-83DA-B0C6155229ADQ38682093-AD6BF8C2-1D9D-4361-953E-51763E216848Q51271590-296C2584-D60C-4322-B337-BDA2F1F02546Q52375183-F5178BDD-37FD-4051-8E83-08895B60DFF0Q55358328-87961A20-8356-4EE9-A9BE-2731214A6028
P2860
Further characterization of the metabolic properties of triglyceride-rich lipoproteins from human and mouse apoC-III transgenic mice
description
1996 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 1996
@ast
im August 1996 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 1996/08/01)
@sk
vědecký článek publikovaný v roce 1996
@cs
wetenschappelijk artikel (gepubliceerd op 1996/08/01)
@nl
наукова стаття, опублікована в серпні 1996
@uk
مقالة علمية (نشرت في أغسطس 1996)
@ar
name
Further characterization of th ...... mouse apoC-III transgenic mice
@ast
Further characterization of th ...... mouse apoC-III transgenic mice
@en
Further characterization of th ...... mouse apoC-III transgenic mice
@nl
type
label
Further characterization of th ...... mouse apoC-III transgenic mice
@ast
Further characterization of th ...... mouse apoC-III transgenic mice
@en
Further characterization of th ...... mouse apoC-III transgenic mice
@nl
prefLabel
Further characterization of th ...... mouse apoC-III transgenic mice
@ast
Further characterization of th ...... mouse apoC-III transgenic mice
@en
Further characterization of th ...... mouse apoC-III transgenic mice
@nl
P2093
P921
P1476
Further characterization of th ...... mouse apoC-III transgenic mice
@en
P2093
Aalto-Setälä K
Bisgaier CL
Breslow JL
Weinstock PH
P304
P577
1996-08-01T00:00:00Z